Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of a New Protocol for Preventing Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions

NCT02468401 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT02468401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02468401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of a New Protocol for Preventing Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
Lead sponsor
Meir Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
August 31, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease, kidney disease, chronic